Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

New understanding and treatments for hair loss are improving, but more research is needed.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Graphene oxide helps deliver a skin healing agent over time, improving skin and hair follicle regeneration.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Mogamulizumab can cause hair loss and skin rashes.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Increasing sebum production might help reduce fat and improve metabolism.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.